Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Protein Engineering, Design & Selection : PEDS|September 17, 2014
Optimizing recombinant antibodies for intracellular function using hitchhiker-mediated survival selectionDujduan Waraho-Zhmayev, Bunyarit Meksiriporn, Alyse D Portnoff, et al.
The Journal of Biological Chemistry|January 30, 2014
Ubiquibodies, synthetic E3 ubiquitin ligases endowed with unnatural substrate specificity for targeted protein silencingAlyse D Portnoff, Erin A Stephens, Jeffrey D Varner, et al.
Scientific Reports|December 23, 2014
An engineered genetic selection for ternary protein complexes inspired by a natural three-component hitchhiker mechanismHyeon-Cheol Lee, Alyse D Portnoff, Mark A Rocco, et al.
The Journal of Biological Chemistry|March 5, 2017
An antidote approach to reduce risk and broaden utility of antibody-based therapeuticsAlyse D Portnoff, Cuihua Gao, M Jack Borrok, et al.
Vaccine|November 3, 2020
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challengeMimi Guebre-Xabier, Nita Patel, Jing-Hui Tian, et al.
Science (New York, N.Y.)|October 21, 2020
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidateSandhya Bangaru, Gabriel Ozorowski, Hannah L Turner, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidateSandhya Bangaru, Gabriel Ozorowski, Hannah L Turner, et al.
Nature Communications|February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsJames Logue, Robert M Johnson, Nita Patel, et al.
Nature Communications|January 15, 2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceJing-Hui Tian, Nita Patel, Robert Haupt, et al.
Pageof 2